• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Characterization of a Novel Entity of G3 (High-grade Well-differentiated) Colorectal Neuroendocrine Tumors (NET) in the SEER Database.

作者信息

Abdel-Rahman Omar

机构信息

Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton AB, Canada.

出版信息

Am J Clin Oncol. 2021 Jan 1;44(1):43. doi: 10.1097/COC.0000000000000777.

DOI:10.1097/COC.0000000000000777
PMID:33337643
Abstract
摘要

相似文献

1
Characterization of a Novel Entity of G3 (High-grade Well-differentiated) Colorectal Neuroendocrine Tumors (NET) in the SEER Database.监测、流行病学与最终结果（SEER）数据库中G3（高分化）结直肠神经内分泌肿瘤（NET）新实体的特征分析
Am J Clin Oncol. 2021 Jan 1;44(1):43. doi: 10.1097/COC.0000000000000777.
2
Characterization of a Novel Entity of G3 (High-grade Well-differentiated) Colorectal Neuroendocrine Tumors (NET) in the SEER Database.在 SEER 数据库中对 G3（高级高分化）结直肠神经内分泌肿瘤（NET）的一种新实体进行特征描述。
Am J Clin Oncol. 2020 Dec 1;43(12):846-849. doi: 10.1097/COC.0000000000000761.
3
A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.胰腺WHO 3级（G3）高分化神经内分泌肿瘤（WD-NET）和低分化神经内分泌癌（PD-NEC）分类的实用方法
Am J Surg Pathol. 2016 Sep;40(9):1192-202. doi: 10.1097/PAS.0000000000000662.
4
Gastroenteropancreatic Well-Differentiated Grade 3 Neuroendocrine Tumors: Review and Position Statement.胃肠胰高分化3级神经内分泌肿瘤：综述与立场声明
Oncologist. 2016 Oct;21(10):1191-1199. doi: 10.1634/theoncologist.2015-0476. Epub 2016 Jul 8.
5
Management of Well-Differentiated High-Grade (G3) Neuroendocrine Tumors.分化良好的高级别（G3）神经内分泌肿瘤的治疗。
Curr Treat Options Oncol. 2019 Aug 19;20(9):74. doi: 10.1007/s11864-019-0670-1.
6
Unmet Needs in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms (WHO G3).高分级胃肠胰神经内分泌肿瘤（WHO G3）中的未满足需求。
Neuroendocrinology. 2019;108(1):54-62. doi: 10.1159/000493318. Epub 2018 Aug 28.
7
Colorectal Neuroendocrine Neoplasms: Areas of Unmet Need.结直肠神经内分泌肿瘤：未满足的需求领域。
Neuroendocrinology. 2019;108(1):45-53. doi: 10.1159/000493767. Epub 2018 Sep 16.
8
Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).神经内分泌肿瘤异质性给 2010 年世界卫生组织分类带来不确定性：来自西班牙肿瘤登记处（R-GETNE）的真实世界数据。
Oncologist. 2018 Apr;23(4):422-432. doi: 10.1634/theoncologist.2017-0364. Epub 2018 Jan 12.
9
The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms.高级别（世界卫生组织G3级）胰腺神经内分泌肿瘤类别在形态学和生物学上具有异质性，包括高分化和低分化肿瘤。
Am J Surg Pathol. 2015 May;39(5):683-90. doi: 10.1097/PAS.0000000000000408.
10
The epidemiology of gastroenteropancreatic neuroendocrine tumors.胃肠胰神经内分泌肿瘤的流行病学。
Endocrinol Metab Clin North Am. 2011 Mar;40(1):1-18, vii. doi: 10.1016/j.ecl.2010.12.005.

引用本文的文献

1
Development of novel prediction models for nodal and distant metastasis in G1 and G2 colorectal neuroendocrine tumors.新型 G1 和 G2 结直肠神经内分泌肿瘤淋巴结和远处转移预测模型的建立。
Int J Colorectal Dis. 2023 Feb 13;38(1):37. doi: 10.1007/s00384-023-04331-x.
2
Tumor Differentiation is the Dominant Prognostic Factor for Patients with Colorectal Neuroendocrine Neoplasms with Distant Metastasis.肿瘤分化是伴有远处转移的结直肠神经内分泌肿瘤患者的主要预后因素。
Int J Endocrinol. 2022 Dec 19;2022:1720624. doi: 10.1155/2022/1720624. eCollection 2022.
3
Tumor Macroscopic Morphology Is an Important Prognostic Factor in Predicting Chemotherapeutic Efficacy and Clinical Outcomes of Patients With Colorectal Neuroendocrine Neoplasms, One Multicenter Retrospective Cohort Study.
肿瘤宏观形态是预测结直肠神经内分泌肿瘤患者化疗疗效和临床结局的重要预后因素：一项多中心回顾性队列研究。
Front Endocrinol (Lausanne). 2021 Dec 20;12:801741. doi: 10.3389/fendo.2021.801741. eCollection 2021.